Implanet S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMPZY research report →
Price Chart
About the company
Implanet S. A. , along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications.
- CEO
- Ludovic Lastennet
- IPO
- 2017
- Employees
- 46
- HQ
- Martillac, NA, FR
Get TickerSpark's AI analysis on IMPZY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $230.11M
- P/E
- -5.47
- PEG
- -0.20
- P/S
- 1.64
- P/B
- -13.09
- EV/EBITDA
- -9.82
- Div Yield
- 0.00%
- Gross Margin
- 58.58%
- Op Margin
- -37.87%
- Net Margin
- -32.07%
- ROE
- 671.47%
- ROIC
- -131.31%
Latest fiscal year · YoY change
- Revenue
- $12.47M+32.6%
- Gross Profit
- $6.89M+68.1%
- Op Income
- $-3,928,000
- Net Income
- $-4,382,000-0.4%
- EPS
- $-0.00+22.7%
- OCF Growth
- +74.7%
- FCF Growth
- +23.5%
- 52W High
- $0.08
- 52W Low
- $0.08
- 50D MA
- $0.08
- 200D MA
- $0.08
- Beta
- 0.63
- RSI (14)
- 100
- Avg Volume
- 4.60K
No earnings-call transcripts are available for IMPZY yet.
- Free Float
- 1.3%
- Shares Outstanding
- 2.88B
- Float Shares
- 36.21M
Our IMPZY coverage
Recent articles, reports, and earnings notes.
No research on IMPZY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMPZY report →